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ABSTRACT The mechanisms underlying neurodevelopmental damage caused by vi-
rus infections remain poorly deﬁned. Congenital human cytomegalovirus (HCMV) in-
fection is the leading cause of fetal brain development disorders. Previous work has
linked HCMV infection to perturbations of neural cell fate, including premature dif-
ferentiation of neural progenitor cells (NPCs). Here, we show that HCMV infection of
NPCs results in loss of the SOX2 protein, a key pluripotency-associated transcription
factor. SOX2 depletion maps to the HCMV major immediate early (IE) transcription
unit and is individually mediated by the IE1 and IE2 proteins. IE1 causes SOX2
downregulation by promoting the nuclear accumulation and inhibiting the phos-
phorylation of STAT3, a transcriptional activator of SOX2 expression. Deranged sig-
naling resulting in depletion of a critical stem cell protein is an unanticipated mech-
anism by which the viral major IE proteins may contribute to brain development
disorders caused by congenital HCMV infection.
IMPORTANCE Human cytomegalovirus (HCMV) infections are a leading cause of
brain damage, hearing loss, and other neurological disabilities in children. We report
that the HCMV proteins known as IE1 and IE2 target expression of human SOX2, a
central pluripotency-associated transcription factor that governs neural progenitor
cell (NPC) fate and is required for normal brain development. Both during HCMV in-
fection and when expressed alone, IE1 causes the loss of SOX2 from NPCs. IE1 medi-
ates SOX2 depletion by targeting STAT3, a critical upstream regulator of SOX2 ex-
pression. Our ﬁndings reveal an unanticipated mechanism by which a common virus
may cause damage to the developing nervous system and suggest novel targets for
medical intervention.
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Congenital human cytomegalovirus (HCMV) infection is the leading cause of birthdefects worldwide. Approximately 1% of live newborns are infected in utero with
the virus. At the time of birth, 5 to 10% of HCMV-infected newborn infants exhibit signs
of neurological damage, such as microcephaly, cerebral calciﬁcation, and other abnor-
mal ﬁndings (1–3). Among infected newborns who have no symptoms at birth, 10 to
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15% subsequently develop central nervous system (CNS) disorders, including senso-
rineural hearing loss, mental retardation, and learning disability (4–6). In addition, some
authors have suggested that autism, language disorders, and other, more subtle
changes in brain development might be related to congenital HCMV infection (7–9).
Although the virus can infect a wide range of cell types and organs in vivo, the fetal
brain is regarded as the principal target of HCMV infection that results in neurological
manifestations (10–12). Due to exquisite host-speciﬁc tropism of the virus and the lack
of animal models that faithfully recapitulate major characteristics of human infection,
the pathogenesis of HCMV-associated disease in the developing CNS is largely un-
known. However, recent advances in human neural progenitor cell (NPC) isolation and
culture have provided an opportunity to study HCMV infection in a cell system relevant
to fetal neuropathogenesis. Our previous studies and the work of others have shown
that human NPCs are susceptible to HCMV infection and fully permissive to viral
replication (13–19). HCMV infection of NPCs affects cell fate by causing premature
differentiation (14, 17, 18). Whole-genome analysis demonstrated that HCMV infection
modulates the expression of NPC markers (14, 19), including sex-determining region Y
(SRY) box 2 (SOX2), a core transcriptional factor for stem cell self-renewal and pluripo-
tency.
SOX2 is widely expressed in early neuroectoderm and neural progenitor cells during
development (14, 19, 20), as well as in neural stem cells in the adult brain (20, 21). SOX2
missense or heterozygous loss-of-function mutations have been found to cause ocular
malformations, often manifesting as anophthalmia, microphthalmia, or coloboma.
These symptoms may be accompanied by hearing loss, learning disability, or brain
malformation (22–24). Familial recurrence of SOX2-associated anophthalmia has been
observed (24). Moreover, the level of SOX2 expression plays an important role in
sensory organ, including inner ear and retina, development. Groundbreaking research
has demonstrated that forced SOX2 expression in ﬁbroblasts, with or without additional
factors, can generate induced pluripotent stem cells (25–27). In fact, ectopic SOX2
expression directs reprogramming of ﬁbroblasts into neural stem or precursor cells (25,
28–30). SOX2 is also critical for maintenance of embryonic stem cells (ESCs). The SOX2
levels in ESCs are tightly regulated (31), and even small changes in expression can lead
to differentiation (32, 33).
STAT3 is a member of the signal transducer and activator of transcription (STAT)
family (34) and is expressed in an activated form in the developing CNS as early as
during initial NPC proliferation. The protein plays a dichotomous regulatory role in
neuro- and gliogenesis (35, 36). STAT3 is activated through phosphorylation of tyrosine
705 (Y705) by receptor-associated kinases in response to various growth factors and
cytokines, including interleukin 6 (IL-6). Tyrosine phosphorylation leads to the nuclear
accumulation of STAT3 homodimers, which act as DNA binding transcriptional activa-
tors of numerous target genes, including the SOX2 gene. In ESCs that are differentiated
into NPCs, STAT3 promotes cell fate commitment by activating the SOX2 gene pro-
moter (37).
Here, we investigate the effects of HCMV infection on SOX2 expression in human
NPCs. We demonstrate that the HCMV 72-kDa immediate early 1 (IE1) protein down-
regulates SOX2 transcription and mediates depletion of the SOX2 protein from HCMV-
infected NPCs. IE1 exerts its effect on SOX2 expression by inactivating the upstream
regulator STAT3.
RESULTS
HCMV infection of NPCs causes downregulation of SOX2 mRNA and protein.
Previous work has established that human NPCs are fully permissive to HCMV infection
(15, 38). As early as 4 h postinfection (hpi), a signiﬁcant decrease of SOX2 mRNA was
observed in NPCs, and this decrease became more apparent as infection progressed
(Fig. 1A). In contrast, SOX2 protein levels did not change in these cells at early times
postinfection (up to 12 hpi), but a gradual decrease was observed at late times (from
24 hpi) compared with mock-infected cells (Fig. 1B). By 48 hpi, the SOX2 protein was
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FIG 1 HCMV infection downregulates SOX2 at the mRNA and protein levels in NPCs. NPC monolayers
were mock infected (M) or infected with HCMV (TNWT) at an MOI of 3 (V) and collected at the indicated
times postinfection for mRNA or protein analyses. (A) SOX2 mRNA levels during HCMV infection of NPCs.
The levels of SOX2 mRNA, normalized to GAPDH, were determined by qRT-PCR at 4 to 120 hpi. The
results shown are averages and SD of data from three independent experiments, each conducted in
triplicate. (B) SOX2 and viral protein levels during HCMV infection of NPCs. SOX2, IE1/IE2, UL44, and gB
steady-state protein levels were determined by Western blotting at 4 to 96 hpi. Actin served as a loading
control. The values listed below the SOX2 blots indicate the relative SOX2 protein levels compared to
corresponding mock-infected controls following actin normalization. ND, not detectable. (C) Cellular
distribution of SOX2 in relation to viral replication compartments during HCMV infection of NPCs. The
distributions of SOX2 and UL44 were determined by indirect immunoﬂuorescence assay at 12 to 48 hpi.
NPCs grown on poly-D-lysine-coated coverslips were stained with antibodies against SOX2 (green) and
(Continued on next page)
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clearly downregulated, and by 96 hpi, it was undetectable. The HCMV proteins IE1/IE2,
UL44, and glycoprotein B (gB) were also analyzed in this experiment to monitor IE, early,
and late viral gene expression, respectively.
In addition, the change in SOX2 protein levels was examined in relation to the
formation and development of HCMV intranuclear replication compartments visualized
via immunoﬂuorescence staining of UL44 (Fig. 1C). UL44 is the processivity factor of the
HCMV DNA polymerase and is ﬁrst expressed in the early phase of infection. Initially,
UL44 was evenly distributed across the infected nucleus; then, it formed multiple small
foci (36 hpi) representing early viral replication compartments; and ﬁnally, the small foci
merged into bipolar foci (48 hpi) or single large late replication compartments (72 hpi)
(data not shown). In mock-infected NPCs, SOX2 exhibited its typical intense and diffuse
nuclear staining. As expected, the SOX2 signal decreased during the course of HCMV
infection inversely related to UL44 focus development. In fact, SOX2 became dispersed
and largely disappeared from late HCMV-infected NPCs.
These observations indicate the presence of a highly effective mechanism for SOX2
depletion in HCMV-infected NPCs.
SOX2 depletion from HCMV-infected NPCs requires de novo viral protein
synthesis. To determine if SOX2 downregulation is dependent on HCMV gene prod-
ucts expressed de novo from the infecting viral genome, NPCs were exposed to
infectious HCMV or UV-inactivated virus, and SOX2 expression was analyzed. As ex-
pected, SOX2 expression was suppressed at both the RNA and protein levels in
infections with the untreated virus (Fig. 2A and B). In contrast, UV-inactivated virus
failed to suppress the expression of SOX2 mRNA (Fig. 2A) and protein (Fig. 2B). Similar
levels of gB derived from the input virus were detected at 12 hpi with both untreated
and UV-treated HCMV, conﬁrming that cells had been exposed to equal amounts of
infecting virus (Fig. 2B). However, de novo synthesis of viral proteins was undetectable
in infections with UV-treated virus, conﬁrming successful inactivation. In another
experiment, NPCs were pretreated with cycloheximide (CHX) and then infected with
HCMV for 4, 8, 12, and 16 h in the presence of CHX. Downregulation of SOX2 mRNA
induced by HCMV infection was signiﬁcantly diminished by CHX treatment at all the
tested time points (Fig. 2C). No obvious change in SOX2 protein levels was observed by
16 hpi (data not shown), consistent with the results shown in Fig. 1 and previous
reports (14, 19).
These results indicate that one or more viral proteins expressed de novo upon HCMV
infection are required for SOX2 downregulation in NPCs.
HCMVmajor IE proteins mediate SOX2 downregulation in NPCs. Transcription of
SOX2 is suppressed as early as 4 hpi, a time when virion constituents and IE gene
products are the only viral components present in the infected cell nucleus. To test
whether IE or tegument proteins are sufﬁcient for SOX2 downregulation, the major IE
proteins (IE1 and IE2) and the most abundant tegument protein (pp65) were individ-
ually expressed in NPCs using nucleofection. In agreement with the conclusion that
newly synthesized viral proteins mediate SOX2 downregulation (Fig. 2), SOX2 levels did
not change in NPCs transiently expressing pp65 compared to control cells (Fig. 3A).
Thus, pp65 was used as a negative control in subsequent assays. Expression of the
entire major IE transcription unit, including the IE1 and IE2 proteins, resulted in
signiﬁcant reduction of SOX2 protein levels (Fig. 3A). To discriminate between effects
on SOX2 expression mediated by IE1 or IE2, each of the two proteins was individually
expressed in NPCs. Following transfection of 2 or 5 g IE1-expressing plasmid, the
relative SOX2 mRNA levels were reduced to 61 or 23% of control levels, and the
corresponding protein levels were reduced to 84 or 33%, respectively (Fig. 3B). Trans-
fection of 2 or 5 g IE2-expressing plasmid reduced the relative SOX2 mRNA levels to
71 or 31% of control levels and the protein levels to 88 or 54%, respectively (Fig. 3C).
FIG 1 Legend (Continued)
UL44 (red), and nuclei were counterstained with Hoechst 33342 (blue). Phase-contrast images are also
shown. Scale bars, 5 m.
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These results indicate that the HCMV IE1 and IE2 proteins both play a signiﬁcant role
in downregulating SOX2 expression. However, IE1 appeared to affect SOX2 more
efﬁciently than IE2. Therefore, and because of the lethal phenotype of IE2-deﬁcient
viruses (39, 40), we focused our study on the role of IE1 in SOX2 regulation in the
present study.
FIG 2 De novo synthesis of HCMV proteins is required for SOX2 downregulation in NPCs. Shown are
comparisons of HCMV infections with active virus (V) and UV-inactivated virus (UV). NPCs were mock
infected (M) or infected with active or UV-irradiated TNWT at an MOI of 3 and collected at the indicated
times postinfection. (A) SOX2 mRNA levels normalized to GAPDH were determined by qRT-PCR. Log10
values of inactivated virus/mock-infected virus (UV/M) and active virus/mock-infected virus (V/M) ratios
are shown. Data from three independent experiments were analyzed by one-way analysis of variance
(ANOVA), and the results are presented as averages and SD. **, P  0.01. (B) Levels of SOX2 and
representative viral proteins (IE1/IE2, UL44, and gB) were determined by Western blotting. Actin served
as a loading control. The values listed below the SOX2 blots indicate the relative SOX2 protein levels
compared to corresponding mock-infected controls following actin normalization. The data are from
three independent experiments, and the results are presented as averages and SD. *, P  0.05; **, P 
0.01. (C) Effect of protein synthesis inhibition by CHX treatment on SOX2 mRNA levels. NPCs were
pretreated with CHX for 1 h prior to infection and then mock infected (M) or infected with HCMV (TNWT)
at an MOI of 3 (V). Cells were collected at 4, 8, 12, and 16 hpi for analysis of SOX2 mRNA by qRT-PCR. Data
from three independent experiments were analyzed by one-way ANOVA, and the results are presented
as averages and SD. *, P  0.05; **, P  0.01.
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HCMV IE1 is required for depletion of SOX2 during infection of NPCs. HCMV
infection and IE1 expression were each sufﬁcient to efﬁciently downregulate SOX2 at
the mRNA and protein levels in NPCs. To conﬁrm the requirement for IE1 for SOX2
depletion during HCMV infection, the expression of IE1 was knocked down using short
hairpin RNAs (shRNAs) targeting IE1 exon 4 sequences. First, human embryonic lung
(HEL) cells were transduced with lentiviruses expressing shRNAs directed against three
different IE1-speciﬁc sequences, sh-1 to sh-3, or a scrambled shRNA control (scr). The
transduced cells were subsequently synchronized and infected with HCMV. Analysis of
IE1 protein levels determined at 24 and 48 hpi showed that sh-2 was the most efﬁcient
among the three tested shRNAs in reducing the levels of the IE1 protein (Fig. 4A). To
conﬁrm the knockdown efﬁciency of sh-2, another experiment was performed in which
both IE1 mRNA and protein were analyzed at 24, 48, and 72 hpi. Again, sh-2 knocked
down IE1 by 60% at the RNA level and 50% at the protein level through the course
of infection (Fig. 4B).
Following the successful IE1 knockdown in HEL cells, NPCs were transduced with
lentiviruses expressing sh-2 or scr. The transduced NPCs were infected with HCMV and
collected at 24 to 60 hpi. Since 24 hpi was previously shown to be the “turning point”
of SOX2 protein levels (Fig. 1), this time point was chosen as the earliest. As shown in
FIG 3 HCMV major IE proteins downregulate SOX2 mRNA and protein in NPCs. HCMV pp65, IE1, IE2, or IE1
and IE2 combined were transiently expressed in NPCs following nucleofection. Samples were collected at
48 h posttransfection for mRNA (qRT-PCR) or protein (Western blotting) analysis. Actin served as a loading
control. Shown is the relative level of SOX2 protein compared to corresponding controls following actin
normalization. Data from three independent experiments were analyzed by one-way ANOVA, and the
results are presented as averages and SD. *, P  0.05; **, P  0.01. (A) Effects of pp65 and major IE proteins
(IE1 and IE2) on SOX2 protein levels. (Left blot) NPCs were transfected with 5 g pcDNA3.0 (Vector) or
pcDNA3-pp65. (Right blot) NPCs were transfected with 5 g pcDNA3-pp65 as a control (Vector) or pSVH
(IE1 and IE2). (B) Effects of IE1 on SOX2 mRNA and protein levels. NPCs were transfected with 5 g
pcDNA3-pp65 (Vector) or 2 to 5 g pcDNA3-IE1. (C) Effects of IE2 on SOX2 mRNA and protein levels. NPCs
were transfected with 5 g pcDNA3-pp65 (Vector) or 2 to 5 g pcDNA3-IE2.
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Fig. 4C, SOX2 protein levels gradually decreased as infection progressed, consistent
with Fig. 1. Signiﬁcant knockdown of IE1 was observed at all tested time points in NPCs
expressing sh-2 compared with scr-expressing cells. SOX2 downregulation was allevi-
ated in HCMV-infected NPCs expressing sh-2 compared to cells expressing scr, most
notably at 60 hpi.
Although the IE1 knockdown was incomplete and linked to reduced levels of other
viral proteins (UL44 and gB), these results support the idea that IE1 contributes to SOX2
downregulation during HCMV infection of NPCs.
HCMV infection and IE1 expression inhibit STAT3 tyrosine phosphorylation
and relocalize unphosphorylated STAT3 to the nuclei of NPCs. So far, our experi-
ments have indicated that HCMV IE1 downregulates SOX2, but a mechanism through
which the viral protein alters expression of the cellular stem cell factor has not been
identiﬁed. Results from coimmunoprecipitation and yeast two-hybrid assays failed to
FIG 4 IE1 knockdown attenuates HCMV-induced SOX2 downregulation in NPCs. (A) IE1-directed knock-
down efﬁciencies of candidate shRNAs in HEL cells. HEL cells were transduced with lentiviruses express-
ing shRNA-IE1-1 (sh-1), shRNA-IE1-2 (sh-2), shRNA-IE1-3 (sh-3), or shRNA-scramble (scr). At 48 h postrans-
duction, the cells were infected with HCMV (TNWT) at an MOI of 1 and collected at 24 or 48 hpi. IE1
protein levels were determined by Western blotting. Actin served as a loading control. (B) IE1-directed
knockdown efﬁciency of sh-2 in HEL cells. HEL cells transduced with sh-2- or scr-expressing lentiviruses
were infected with HCMV (TNWT) as for panel A. (Left) IE1 mRNA levels were determined by qRT-PCR at
the indicated times postinfection; data from two independent experiments were analyzed by one-way
ANOVA, and the results are presented as averages and SD. *, P  0.05; **, P  0.01. (Right) Protein levels
were determined at the indicated times by Western blotting. (C) Effects of sh-2 on IE1 and SOX2
expression in NPCs. NPCs were transduced with sh-2- or scr-expressing lentiviruses, cultured for 48 h,
reseeded at a density of 3  106 cells/dish, and mock infected (M) or infected with TNWT at an MOI of
1 (V). Protein levels of IE1, UL44, gB, and SOX2 at the indicated times postinfection are shown. Actin
served as a loading control.
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provide evidence for a physical interaction between IE1 and SOX2 (data not shown).
Since SOX2 expression was affected at both the protein and RNA levels, it also seemed
more likely that IE1 interferes with the transcription rather than the protein stability of
SOX2. One key transcription factor regulating SOX2 expression is STAT3 (37), which has
been recently identiﬁed as a physical interaction partner of IE1 (41, 42).
To investigate whether HCMV infection and IE1 expression affect SOX2 levels via
modulation of STAT3 activation, the levels of total and tyrosine (Y705)-phosphorylated
STAT3 (pSTAT3) were determined in infected NPCs. HCMV infection dramatically sup-
pressed STAT3 tyrosine phosphorylation as early as 4 hpi, and pSTAT3 was maintained
at low levels throughout the course of infection compared to mock-infected NPCs. In
contrast, the total STAT3 levels showed little if any change during infection (Fig. 5A).
STAT3 is a nucleocytoplasmic shuttling protein that is efﬁciently exported from the
nucleus in its unphosphorylated form (43). Unphosphorylated STAT3 is therefore
typically located in the cytoplasm or distributed across both the nuclear and cytoplas-
mic compartments. However, upon tyrosine phosphorylation, pSTAT3 efﬁciently accu-
mulates in the nucleus (37, 44, 45). To deﬁne the subcellular distribution of STAT3 in
HCMV-infected NPCs, we performed immunoﬂuorescence analysis. NPCs on coverslips
were infected with HCMV (multiplicity of infection [MOI]  1), collected at 8 hpi, and
stained for STAT3 and IE1/IE2. STAT3 was mainly conﬁned to the nuclei of virus-infected
cells, while in mock-infected cells, the STAT3 signal was more diffuse and was cyto-
plasmic as well as nuclear (Fig. 5B). This observation was consistent with our results
from HCMV-infected ﬁbroblasts (41, 42). To further investigate STAT3 subcellular local-
ization in HCMV-infected NPCs, the levels of pSTAT3 and total STAT3 in cytoplasmic and
nuclear compartments separated by cellular fractionation were analyzed at 4 and 8 hpi.
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and lamin B1 served as loading
controls for the cytoplasmic and nuclear compartments, respectively, conﬁrming suc-
cessful fractionation. As expected, pSTAT3 was present predominantly in the nuclei of
both mock- and HCMV-infected cells. Compared to mock-infected NPCs, pSTAT3 levels
were reduced in both the cytoplasm and nucleus in HCMV-infected cells at 4 and 8 hpi.
Total STAT3 resided mainly in the cytoplasm, but the nuclear signal was much stronger
in HCMV-infected than in mock-infected cells at both tested time points (Fig. 5B). These
results indicate that HCMV infection reduces the levels of activated STAT3 (pSTAT3) and
promotes the nuclear accumulation of unphosphorylated STAT3 at very early times of
infection in NPCs.
IE proteins are thought to be the only HCMV gene products expressed at 4 to 8 hpi,
when STAT3 is relocalized to the nucleus and its phosphorylation is inhibited. To test
whether IE1 was responsible for the observed effects on STAT3, the viral protein was
transiently expressed in NPCs. IE1 expression was sufﬁcient to downregulate pSTAT3
levels and to sequester an unphosphorylated form of the cellular protein in the nuclear
compartment (Fig. 5C). To investigate whether IE1 has a dose-dependent inhibitory
effect on STAT3 phosphorylation, pSTAT3 levels in NPCs nucleofected with different
amounts of IE1-expressing plasmid were compared by Western blotting. An inverse
correlation between IE1 and pSTAT3 levels was observed in these experiments, indi-
cating that IE1 downregulates pSTAT3 in a dose-dependent manner (Fig. 5D). To further
conﬁrm the role of IE1 in altering STAT3 phosphorylation and intracellular localization,
NPCs were mock infected or infected with wild-type (WT), IE1-deﬁcient variant strain
(dlIE1), or IE1-revertant variant strain (rvIE1) viruses. The levels of viral proteins (UL44
and gB) were similar, except that IE1 was absent and downregulation of SOX2 was
diminished in the infection with dlIE1 (Fig. 5E). Compared with mock-infected cells, the
pSTAT3 levels were reduced in WT- and rvIE1-infected cells, but not in dlIE1-infected
cells. Again, the overall steady-state STAT3 levels were rather constant across all mock-
and HCMV-infected samples (Fig. 5F). Finally, based on cellular-fractionation analysis,
pSTAT3 was located in the nuclei of both mock- and WT- or dlIE1-infected cells. Total
STAT3 localized mainly in the cytoplasm of mock- and dlIE1-infected cells, while
increased nuclear localization was observed in WT-infected NPCs (Fig. 5G).
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FIG 5 HCMV infection or IE1 expression inhibits STAT3 tyrosine phosphorylation and promotes nuclear
accumulation of unphosphorylated STAT3 in NPCs. (A) Inhibition of STAT3 tyrosine (Y705) phosphory-
lation by HCMV infection. NPCs were mock infected (M) or infected with TNWT at an MOI of 3 (V) and
collected at the indicated times postinfection. The protein levels of IE1, pSTAT3, and total STAT3 were
determined by Western blotting. Actin served as a loading control. (B) Nuclear trapping of STAT3 by
HCMV infection. NPCs were mock infected (M) or -infected with TNWT at an MOI of 1 (V). (Left) For
indirect immunoﬂuorescence analysis, NPCs on coverslips collected at 8 hpi were stained with antibodies
against STAT3 (green) or IE1/IE2 (red), and nuclei were counterstained with Hoechst 33342 (blue).
Infected (IE1/IE2-positive) cells are indicated by arrows. Scale bar, 10 m. (Right) For cellular-fractionation
analysis, fractions enriched in cytoplasmic (Cyt) or nuclear (Nuc) proteins were prepared from cells
collected at 4 or 8 hpi. Protein levels of pSTAT3 and total STAT3 in each fraction were determined by
Western blotting. GAPDH and lamin B1 served as controls for the Cyt and Nuc fractions, respectively. (C
to G) Inhibition of tyrosine phosphorylation and nuclear sequestration of unphosphorylated STAT3 by
IE1. Fractions enriched in cytosolic or nuclear proteins or total cell extracts were prepared. (C) For
transient-transfection analysis, NPCs were nucleofected with pcDNA3-IE1 or empty vector (Ctrl) and
harvested at 48 h postnucleofection. Protein levels of IE1, pSTAT3, and total STAT3 were determined by
Western blotting. GAPDH and lamin B1 served as controls for the Cyt and Nuc fractions, respectively. (D)
To examine dose-dependent effects of IE1 on pSTAT3 levels, NPCs transfected with the indicated
amounts of pcDNA-IE1 and empty vector (pcDNA3.0) were harvested 48 h postnucleofection. The protein
(Continued on next page)
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These results demonstrate that IE1 is both sufﬁcient and required for the inhibition
of tyrosine phosphorylation and nuclear sequestration of unphosphorylated STAT3
observed during HCMV infection of NPCs.
SOX2 downregulation in HCMV-infected NPCs results from IE1-mediated inhi-
bition of STAT3 activation. The results thus far obtained were all consistent with a
mechanism in which IE1 mediates SOX2 downregulation by limiting STAT3 activation.
To further test this possibility, we performed several different experiments. We ﬁrst
treated NPCs with cryptotanshinone (CTS), a chemical inhibitor of STAT3 tyrosine
phosphorylation (46). In the presence of CTS, pSTAT3 levels (but not steady-state STAT3
levels) markedly decreased as a function of the time of treatment coinciding with
gradual loss of SOX2 (Fig. 6A). Then, STAT3 expression was silenced using RNA
interference. Two different shRNAs, shSTAT3-1 and shSTAT3-2, knocked down STAT3
expression with different efﬁciencies compared to nonspeciﬁc shRNAs (shLuci and
shDsRed). The extent of STAT3 silencing correlated with differential reduction in
pSTAT3 levels, in turn correlating with the levels of SOX2 (Fig. 6B).
In addition to the experiments involving inhibition of STAT3, we set out to study the
IE1-STAT3-SOX2 axis by activating STAT3 signaling. To this end, we ﬁrst treated NPCs
with IL-6, a major agonist of STAT3 signaling (47). IL-6 treatment led to a marked
increase in pSTAT3 without signiﬁcantly affecting the overall STAT3 protein levels.
Concurrent with increased STAT3 tyrosine phosphorylation, there was also a rise in
SOX2 levels. These data were consistent with the ﬁnding that pSTAT3 promotes SOX2
expression in NPCs (Fig. 6C). Next, we transiently expressed IE1 in NPCs; treated the cells
with IL-6 for 4 h or left them untreated; and analyzed the levels of IE1, pSTAT3, total
STAT3, and SOX2. Both pSTAT3 and SOX2 were strongly upregulated by IL-6 but
downregulated by IE1, and IL-6 efﬁciently counteracted IE1-mediated downregulation
of pSTAT3 and SOX2. Again, the total steady-state STAT3 levels did not signiﬁcantly
change upon IL-6 treatment or IE1 expression (Fig. 6D). Finally, to further investigate
the link between IE1 expression, STAT3 activation, and SOX2 regulation in the context
of HCMV infection, NPCs were mock infected or infected with HCMV WT or dlIE1. The
infected NPCs were treated with IL-6 for 4 h or left untreated prior to collection at 24
and 48 hpi. As expected, IL-6 treatment led to elevated levels of pSTAT3 and SOX2 in
mock-, WT-, and dlIE1-infected NPCs. HCMV WT infection reduced the pSTAT3 levels
slightly at 24 hpi and dramatically at 48 hpi. In contrast, no obvious decrease of pSTAT3
was observed following dlIE1 infection. Concordantly, SOX2 protein levels fell substan-
tially in WT infection at 48 hpi but remained constant in dlIE1 infection at the same time
point. Again, IL-6 treatment counteracted IE1-dependent downregulation of both
pSTAT3 and SOX2 (Fig. 6E).
In summary, these data demonstrate that SOX2 expression in NPCs strictly depends
on pSTAT3 and that there is a causal link between SOX2 downregulation by HCMV and
inhibition of STAT3 activation by IE1, including inhibition of tyrosine phosphorylation
and trapping of unphosphorylated STAT3 in the nucleus.
DISCUSSION
Proliferation, differentiation, and migration of NPCs, as well as synapse formation
among mature neurons, are all critical factors for fetal brain development and function
(48–50). HCMV infection has been shown to induce neural cell loss and abnormal
differentiation of NPCs (14, 15, 19). This was not only demonstrated in vitro, but also
conﬁrmed in a mouse model of congenital infection, where the virus appeared to affect
NPCs in the subventricular zone (12). Although HCMV is the leading cause of neuro-
FIG 5 Legend (Continued)
levels of IE1, STAT3, pSTAT3, and SOX2 were determined by Western blotting. *, P  0.05. (E to G) For
HCMV infection analysis, NPCs were mock infected (M) or infected with TNWT (WT), TNdlIE1 (dlIE1), or
TNrvIE1 (rvIE1) viruses at an MOI of 10. The levels of the indicated viral and cellular proteins in whole-cell
extracts at 72 hpi (E) and 24 hpi (F) or in the Cyt and Nuc fractions at 24 hpi (G) were determined by
Western blotting. Actin, GAPDH, and lamin B1 served as controls for total extracts or Cyt and Nuc
fractions, respectively. *, P  0.05; **, P  0.01.
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FIG 6 SOX2 expression strictly depends on pSTAT3, and IE1 mediates SOX2 depletion by inhibiting
STAT3 activation. (A) Inhibition of STAT3 correlates with suppression of SOX2 expression. NPCs were
treated with the chemical inhibitor CTS for the indicated times. The protein levels of total STAT3, pSTAT3,
and SOX2 were determined by Western blotting. Actin served as a loading control. Und, undetectable.
(B) Silencing of STAT3 correlates with suppression of SOX2 expression. NPCs were transduced with the
lentivirus Tet-pLKO-puro-shLuci (shLuci), Tet-pLKO-puro-shDsRed (shDsRed), Tet-pLKO-puro-shSTAT3-1
(shSTAT3-1), or Tet-pLKO-puro-shSTAT3-2 (shSTAT3-2) and treated with doxycycline for 48 h to induce
shRNA expression. The protein levels of total STAT3, pSTAT3, and SOX2 were determined by Western
blotting. Actin served as a loading control. (C) IL-6-mediated activation of STAT3 correlates with
induction of SOX2 expression. NPCs were treated with IL-6 for 2 or 24 h. The protein levels of pSTAT3,
total STAT3, and SOX2 were monitored by Western blotting. Actin served as a loading control. Data from
three independent experiments were analyzed by one-way ANOVA, and the results are presented as
averages and SD. *, P  0.05; **, P  0.01. (D) IL-6 counteracts IE1-dependent SOX2 downregulation in
transiently transfected NPCs. NPCs were transfected with pcDNA3-IE1, treated with IL-6 for 4 h or left
untreated, and collected at 48 h posttransfection. The protein levels of IE1, total STAT3, pSTAT3, and
SOX2 were determined by Western blotting. Actin served as a loading control. Data from three
independent experiments were analyzed by one-way ANOVA, and the results are presented as averages
and SD. *, P  0.05; **, P  0.01. (E) IL-6 counteracts IE1-dependent SOX2 downregulation in HCMV-
infected NPCs. NPCs were infected with TNWT or TNdlIE1 virus at an MOI of 10, treated with IL-6 for 4 h
(Continued on next page)
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logical damage in children, the mechanisms by which the virus perturbs NPC prolifer-
ation and differentiation have remained unclear.
SOX2 is a master controller of stem cells, which is strikingly illustrated by the fact
that its overexpression can reprogram terminally differentiated ﬁbroblasts into induced
pluripotent stem cells (25–30). More speciﬁcally, SOX2 is a transcription factor essential
for maintaining self-renewal and pluripotency of ESCs and NPCs. SOX2 mutations cause
symptoms resembling damage resulting from congenital HCMV infection, including
neural development disorders accompanied by ocular malformation (22–24). In this
study, we demonstrate that HCMV signiﬁcantly downregulates SOX2 mRNA levels in
human primary NPCs from as early as 4 hpi, extending our previous observations (14,
38). The reduced mRNA levels subsequently lead to almost full depletion of the SOX2
protein from HCMV-infected cells at later times (24 to 96 hpi). The temporal delay
between mRNA and protein downregulation suggests that the SOX2 protein may be
very stable in NPCs, in contrast to what has been reported for ESCs (51). The timing of
changes in SOX2 mRNA levels and the observation that the downregulation depends
on de novo viral protein synthesis pointed us to the HCMV major IE proteins as potential
regulators of this stem cell factor. The 72-kDa IE1 and the 86-kDa IE2 proteins subse-
quently proved to be sufﬁcient to decrease SOX2 mRNA and protein levels in the
absence of other viral proteins, together and individually. IE1 and IE2 are nuclear-
localized key regulators of viral and cellular transcription during infection (52–54). They
have been extensively studied in ﬁbroblasts, but there is little information on how the
proteins behave in cell types more relevant to HCMV pathogenesis.
Our results demonstrate that the HCMV IE1 protein is not only sufﬁcient, but also
necessary, for the reduction of SOX2 levels through the early and late stages of
infection. As noted above, the downregulation of SOX2 RNA and protein was also
observed with ectopically expressed HCMV IE2, but that protein appeared to be less
efﬁcient than IE1 in this respect. We propose that IE2 also contributes to SOX2
downregulation in the context of HCMV infection, although this remains to be formally
shown. Due to the difﬁculties in working with IE2-deﬁcient viruses (IE2 is essential for
HCMV replication and is difﬁcult to complement), we focused on IE1 in this study. Our
ﬁndings may come as a surprise in the light of two previous reports that concluded that
HCMV infection or IE1 expression leads to increased instead of decreased SOX2 levels
in human glioma stem-like cells, human glioblastoma cells, and mouse glioma tissue
(55, 56). The seemingly disparate ﬁndings might be due to differences in cell types or
virus strains. However, in our hands, IE1 induced robust inhibition of STAT3 activation
in all cell types tested so far, including glioblastoma-derived cell lines (data not shown).
Notably, the previous studies did not discriminate between the levels of SOX2 in
IE1-expressing cells and IE1-negative cells in the same culture or tumor. Even if the
STAT3 pathway is inhibited in HCMV-infected cells or cells ectopically expressing IE1,
the secretome associated with these cells may trigger STAT3 signaling in IE1-negative
bystander cells. In population analyses, this bystander effect may be detected as an
overall increase in STAT3-dependent gene expression (42).
Our work also determines the molecular events underlying IE1-dependent SOX2
downregulation, which appear to be intimately linked to JAK-STAT signaling. JAK-STAT
(STAT1 and STAT3) signaling pathways play an important role in neural development
by regulating NPC neurogenesis and gliogenesis (35, 36). IE1 markedly affects the
activation state and subcellular localization of STAT3, a key regulatory protein known
to affect the pluripotency of ESCs and to initiate the commitment to NPC fate via
transcriptional activation of SOX2 (37). IE1 inhibits tyrosine (Y705) phosphorylation
and promotes nuclear accumulation of STAT3 without altering the protein’s overall
FIG 6 Legend (Continued)
or left untreated, and collected at 48 hpi. The protein levels of IE1/IE2, total STAT3, pSTAT3, and SOX2
were determined by Western blotting. Actin served as a loading control. Data from three independent
experiments were analyzed by one-way ANOVA, and the results are presented as averages and SD. *, P
0.05; **, P  0.01.
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steady-state levels. These observations closely recapitulate previous results in
ﬁbroblasts and are likely the consequence of a direct physical interaction between
IE1 and STAT3 (41, 42). Although paradoxical on its face, decreased tyrosine
phosphorylation and increased nuclear localization of STAT3 may be coupled. STAT
proteins, including STAT3, continually shuttle between the cytoplasm and the
nucleus. In fact, STAT3 is imported to the nucleus independently of tyrosine
phosphorylation, and this is normally followed by export to the cytoplasm. Tyrosine
phosphorylation transiently increases STAT3 nuclear accumulation due to seques-
tration by DNA binding or heterodimerization with other phosphorylated STAT
proteins (43). Likewise, IE1 may bind to STAT3 passing through the nucleus. Nuclear
sequestration may reduce the amounts of STAT3 undergoing export to the cyto-
plasm and, consequently, the pools of cytoplasmic STAT3 available for tyrosine
phosphorylation by the corresponding (cytoplasmic) JAK family kinases. The ex-
pected consequences of depleting activatable STAT3 by nuclear sequestration are
in line with the reduced pSTAT3 levels, restricted responsiveness to IL-6, and
diminished expression of SOX2 we observed in HCMV-infected NPCs.
In summary, this study for the ﬁrst time links the interaction between IE1 and STAT3
to SOX2 depletion and thereby identiﬁes a novel pathway predicted to contribute to
developmental neuropathogenesis caused by congenital HCMV infection.
MATERIALS AND METHODS
Ethics statement. Postmortem fetal brain tissues from different gestational age cases were obtained
according to an approval notice from the Institutional Review Board (IRB) (WIVH10201202) and the
Guidelines for Biomedical Research Involving Human Subjects at Wuhan Institute of Virology, Chinese
Academy of Sciences. The original source of the anonymized tissues was Zhongnan Hospital of Wuhan
University (China). The cell isolation procedures and research plans were approved by the IRB
(WIVH10201202) according to the Guidelines for Biomedical Research Involving Human Subjects at
Wuhan Institute of Virology, Chinese Academy of Sciences. The need for written or oral consent was
waived by the IRB (57).
Cells and cell culture. All cells were maintained at 37°C in a humidiﬁed atmosphere containing 5%
CO2. NPCs were isolated as described previously (38, 58) and cultured in a 1:1 mixture of growth medium
and conditioned medium (14, 15, 19). The NPC growth medium was Dulbecco’s modiﬁed Eagle medium
(DMEM)-F12 (Thermo Fisher Scientiﬁc) supplemented with 2 mM GlutaMax (Thermo Fisher Scientiﬁc), 100
U/ml penicillin and 100 g/ml streptomycin (Thermo Fisher Scientiﬁc), 50 g/ml gentamicin (Sigma), 1.5
g/ml amphotericin B (Thermo Fisher Scientiﬁc), 10% BIT 9500 (Stem Cell Technologies), 20 ng/ml
epidermal growth factor (EGF) (Prospec), and 20 ng/ml basic ﬁbroblast growth factor (FGF) (Prospec).
Conditioned medium was collected from cultured NPCs and stored at 20°C after cell debris had been
removed by centrifugation. NPCs were maintained as monolayers in ﬁbronectin-coated dishes and
seeded at a deﬁned density into dishes coated with poly-D-lysine (50 g/ml; Millipore) prior to infection.
In order to induce STAT3 activation, NPCs were treated with carrier-free recombinant human IL-6 (183
ng/ml; BioLegend) for the indicated times before being collected for protein analysis. To inhibit STAT3
activation, NPCs were treated for the indicated times with 10 M CTS (Sigma), a small molecular inhibitor
of STAT3 tyrosine (Y705) phosphorylation.
HEL cells maintained in the laboratory and HEL cells immortalized by transfection with pCI-neo-hTERT
(HELf cells, kindly provided by J. Chen, Columbia University), were cultured in minimal essential medium
(MEM) (Thermo Fisher Scientiﬁc). Human embryonic kidney (HEK) 293T cells (CRL-11268) were grown in
DMEM. Both MEM and DMEM were supplemented with 10% fetal bovine serum (FBS) (Thermo Fisher
Scientiﬁc), penicillin and streptomycin, and 2 mM L-glutamine (Thermo Fisher Scientiﬁc). For the
establishment of an IE1-expressing HELf cell line, a lentivirus stock was prepared from plasmid pCDH-
puro-IE1. A volume of 2 ml of this stock was used to transduce 1  106 HELf cells. The transduced cells
were cultured in normal medium for 2 days to allow transgene expression and then switched to selection
medium containing 8 g/ml puromycin (Sigma) for 2 weeks with medium changes every other day.
Expression of IE1 was conﬁrmed by Western blotting. The resulting HELf cell line stably expressing IE1
was designated HELf-IE1 and maintained in medium containing puromycin (4 g/ml).
Plasmids and nucleofection. Plasmids pcDNA3-IE1 and pcDNA3-IE2 were constructed by subclon-
ing a BamHI-BamHI fragment containing the full-length coding sequence of the HCMV 72-kDa IE1 or
86-kDa IE2 protein, respectively, from pSG-IE1 or pSG-IE2 (kindly provided by E. A. Fortunato, University
of Idaho), respectively, into the backbone of pcDNA3.0. Plasmid pcDNA3-pp65 was generated by cloning
a fragment PCR ampliﬁed from HCMV (Towne) cDNA between the BamHI and EcoRI sites of pcDNA3.0
(57). Plasmid pSVH (kindly provided by Q. Tang, Howard University) containing the entire HCMV major
IE transcription unit (including IE1, IE2, and the major IE promoter-enhancer) was also used.
Plasmids expressing shRNAs directed against HCMV (Towne) IE1 sequences were constructed based
on lentiviral vector pLKO.1 puro (Addgene; plasmid 8453). Three shRNAs targeting IE1 exon 4 and a
scrambled shRNA not targeting any viral or human gene were designed (http://jura.wi.mit.edu/bioc/
siRNAext), synthesized, and inserted between the AgeI and EcoRI sites of pLKO.1 puro to generate
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pLKO.1-shRNA-IE1-1 (sh-1), pLKO.1-shRNA-IE1-2 (sh-2), pLKO.1-shRNA-IE1-3 (sh-3), and pLKO.1-scramble
(scr), respectively. The sequences are listed in Table 1. For the establishment of HELf-IE1 cells (described
above), a fragment containing the IE1 coding sequence was recovered from pSG-IE1 and cloned into the
BamHI site of pCDH-CMV-MCS-EF1-puro (System Biosciences). The resulting construct was designated
pCDH-puro-IE1.
Plasmids expressing shRNAs directed against human STAT3 sequences were constructed based
on the lentiviral vector Tet-pLKO-puro (Addgene; plasmid 21915). Two shRNA plasmids targeting
STAT3, Tet-pLKO-puro-shSTAT3-1 and Tet-pLKO-puro-shSTAT3-2, were generated by inserting an-
nealed oligonucleotides 1102 and 1103 or 1134 and 1135, respectively, between the EcoRI and AgeI
sites of Tet-pLKO-puro. Likewise, plasmids Tet-pLKO-puro-shLuci and Tet-pLKO-puro-shDsRed ex-
pressing shRNAs directed against Photinus luciferase or Discosoma red ﬂuorescent protein se-
quences, respectively, not present in human cells were constructed by inserting annealed oligonu-
cleotides 1098 and 1099 or 1038 and 1039, respectively, between the EcoRI and AgeI sites of
Tet-pLKO-puro. The oligonucleotide sequences are listed in Table 1.
To transiently overexpress individual viral proteins, NPCs were transfected with plasmids pSVH,
pcDNA3-IE1, pcDNA3-IE2, pmaxGFP (provided by Lonza to assess transfection efﬁciency), pcDNA3-pp65,
or empty vector (pcDNA3.0) using Nucleofector technology (Lonza) according to the manufacturer’s
instructions. In brief, 5  106 NPCs were mixed with 100 l mesenchymal stem cell (MSC) nucleofector
solution (82 l nucleofector solution with 18 l supplement 1 [Lonza]) and a total of 5 g pSVH,
pcDNA3-IE1, pcDNA3-IE2, pmaxGFP, pcDNA3-pp65, pcDNA3.0, or pcDNA3-IE1, along with pcDNA3.0. The
cell-DNA suspension was transferred to certiﬁed cuvettes, which were inserted into a Nucleofector II
(Lonza), and program A-033 was applied. Immediately following nucleofection, 500 l NPC growth
medium was added to the cuvette, and the sample was gently transferred to poly-D-lysine-coated dishes.
After 24 h, the culture medium was replaced, and cells were analyzed at 48 h postnucleofection.
HCMV preparation and infection. Enhanced green ﬂuorescent protein (EGFP)-expressing bacterial
artiﬁcial chromosome-derived wild-type (T-BAC; referred to here as TNWT), IE1-deﬁcient (TNdlIE1), and
revertant (TNrvIE1) variants of the HCMV Towne strain (ATCC VR977) and the parental virus HCMV Towne
strain (ATCC VR977) were used in this study. The construction of TNdlIE1 and TNrvIE1 was described
previously (59). The TNWT and TNrvIE1 viruses were propagated in HEL cells and titrated by plaque assay
as described previously (60, 61). The TNdlIE1 mutant was propagated and titrated in HELf-IE1 cells. HCMV
particles from infected cell supernatants were concentrated by ultracentrifugation, after removing the
cell debris by high-speed centrifugation, and resuspended in NPC growth medium to avoid any potential
undesired effects induced by components (including FBS) in the medium used for virus preparation (61).
UV-inactivated HCMV was prepared by exposure to 6,000 J/cm2 in a CL-1000 UV cross-linker (UVP), and
sodium pyruvate was added to a ﬁnal concentration of 5 mM to prevent damage from free radicals
induced by UV radiation (62).
For NPC infections, conﬂuent cell monolayers on ﬁbronectin-coated dishes were dissociated using
Accutase (Millipore), 3  106 cells were reseeded in poly-D-lysine-coated 100-mm dishes or uncoated
dishes with poly-D-lysine-coated coverslips, and the cells were allowed to attach overnight. The cells were
exposed to HCMV at the indicated MOI. For the evaluation of IE1-directed shRNAs, NPCs or HEL cells were
TABLE 1 Oligonucleotides used in this study
Purpose Name Sequence (5=–3=)
IE1 knockdown scr F CCGGCCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGGTTTTTG
scr R AATTCAAAAACCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG
sh-1 F CCGGGCATGTATGAGAACTACATTGCTCGAGCAATGTAGTTCTCATACATGCTTTTTG
sh-1 R AATTCAAAAAGCATGTATGAGAACTACATTGCTCGAGCAATGTAGTTCTCATACATGC
sh-2 F CCGGGCTGTGCTGCTATGTCTTAGACTCGAGTCTAAGACATAGCAGCACAGCTTTTTG
sh-2 R AATTCAAAAAGCTGTGCTGCTATGTCTTAGACTCGAGTCTAAGACATAGCAGCACAGC
sh-3 F CCGGGCCTGAGGTTATCAGTGTAATCTCGAGATTACACTGATAACCTCAGGCTTTTTG
sh-3 R AATTCAAAAAGCCTGAGGTTATCAGTGTAATCTCGAGATTACACTGATAACCTCAGGC
STAT3 knockdown #1102 CCGGGCCTCAAGATTGACCTAGACTCGAGTCTAGGTCAATCTTGAGGCTTTTT
#1103 AATTAAAAAGCCTCAAGATTGACCTAGACTCGAGTCTAGGTCAATCTTGAGGC
#1134 CCGGAGTCAGGTTGCTGGTCAAACTCGAGTTTGACCAGCAACCTGACTTTTTT
#1135 AATTAAAAAAGTCAGGTTGCTGGTCAAACTCGAGTTTGACCAGCAACCTGACT
#1098 CCGGGTGCGTTGCTAGTACCAACCTCGAGGTTGGTACTAGCAACGCACTTTTT
#1099 AATTAAAAAGTGCGTTGCTAGTACCAACCTCGAGGTTGGTACTAGCAACGCAC
#1138 CCGGGTGGGAGCGCGTGATGAACCTCGAGGTTCATCACGCGCTCCCACTTTTT
#1139 AATTAAAAAGTGGGAGCGCGTGATGAACCTCGAGGTTCATCACGCGCTCCCAC
PCR pp65 F CGCGGATCCATGGAGTCGCGCGGTCGCCGT
pp65 R CCGGAATTCTCAACCTCGGTGCTTTTTGGG
qRT-PCR SOX2 F GCCGAGTGGAAACTTTTGTCG
SOX2 R GCAGCGTGTACTTATCCTTCTT
GAPDH F GAGTCAACGGATTTGGTCGT
GAPDH R GACAAGCTTCCCGTTCTCAG
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infected with HCMV at an MOI of 1. To overcome the delayed infection process of TNdlIE1, an MOI of 10
was used. After incubation for 3 h to allow virus adsorption, the inoculum was removed and the cells
were refed with fresh medium. Cells were collected and analyzed at the indicated times postinfection. To
study infection in the absence of de novo protein synthesis, NPCs were pretreated with 10 g/ml CHX
(Sigma) for 1 h prior to infection, infected with HCMV in the presence of CHX (10 g/ml), and collected
at 16 hpi for RNA and protein analysis.
Lentivirus preparation and transduction. Stocks of replication-defective lentiviruses were pre-
pared as described previously (57, 63). Brieﬂy, 1.5  106 HEK 293T cells were seeded in a 100-mm dish.
The next day, calcium phosphate precipitation was applied to cotransfect the cells with the packaging
plasmids pML-Δ8.9 (12 g) and pVSV-G (8 g) (System Biosciences), along with 15 g of one of the
following expression plasmids: pCDH-puro-IE1, pLKO.1-scramble, pLKO.1-shRNA-IE1-1, pLKO.1-shRNA-
IE1-2, pLKO.1-shRNA-IE1-3, Tet-pLKO-puro-shDsRed, Tet-pLKO-puro-shLuci, Tet-pLKO-puro-shSTAT3-1, or
Tet-pLKO-puro-shSTAT3-2. Following a medium change, the lentivirus-containing supernatants were
collected 72 h after transfection and stored at 80°C.
The lentivirus stocks were used to transduce HEL cells, HELf cells, or NPCs. To this end, 5  106 NPCs
were seeded in ﬁbronectin-coated dishes and infected with equal volumes (2 ml) of lentivirus stock on
the following day. Lentivirus stock was added to the NPCs again on the next day. The inoculum was
replaced with fresh culture medium 3 h after each transduction. Likewise, 5 105 HEL cells were infected
with 2 ml lentivirus stock on the day following seeding, and the inoculum was replaced with fresh culture
medium 5 h after infection. The transduced cells were cultured for 3 days to allow transgene expression
before they were subjected to HCMV infection and/or RNA or protein analysis. The transduction
procedure used to establish HELf-IE1 cells is described above.
Gene silencing with shRNAs. To determine the IE1-speciﬁc silencing efﬁciency, equal amounts of
shRNA-expressing lentiviruses (sh-1, sh-2, sh-3, and scr) were used to transduce HEL cells in parallel. The
resulting HEL cells were cultured for 2 days to allow shRNA expression, and this was followed by 2 days
of serum starvation with serum-free medium to synchronize the cells. The synchronized cells were
reseeded in 60-mm dishes (1 106 cells/dish), allowed to attach, and infected with HCMV (MOI 1). The
infected cells were collected at 24 and 48 hpi, and the levels of IE1 were determined by protein analysis.
After selection of the most efﬁcient shRNA (sh-2), NPCs were transduced with sh-2 and scr lentiviruses
in parallel. The transduced NPCs were cultured for 48 h to allow shRNA expression, reseeded in
poly-D-lysine-coated dishes (3  106 cells/dish), and infected with HCMV (MOI  1) on the following day.
Cells were collected at the indicated times postinfection and subjected to protein and RNA analysis.
NPCs transduced with the shRNA-expressing lentivirus Tet-pLKO-puro-shDsRed, Tet-pLKO-puro-
shLuci, Tet-pLKO-puro-shSTAT3-1, or Tet-pLKO-puro-shSTAT3-2 (described above) were treated with 1
g/ml doxycycline hyclate (Dox) (Aladdin) for 48 h, with a medium change after 24 h, to induce shRNA
expression. Cells were collected and analyzed at the indicated times.
Quantitative reverse transcriptase (qRT) PCR. Transfected or infected NPCs were collected at the
indicated times. Total RNA was isolated using the RNAiso Plus reagent (TaKaRa), followed by RNase-free
DNase I (Thermo Fisher Scientiﬁc) treatment to remove residual genomic DNA. Equal amounts (500 ng)
of DNA-free RNA were reverse transcribed using the PrimeScript RT reagent kit (Perfect Real Time;
TaKaRa) according to the manufacturer’s instructions. Then, quantitative PCR (qPCR) was performed in a
CFX96 Connect real-time PCR detection system (Bio-Rad). Each 20-l qPCR mixture contained 2 l
reverse transcription product, 10 l 2 iTaq Universal SYBR green Supermix (Bio-Rad), and 200 nM
forward (F) and reverse (R) primers. The primer sequences are shown in Table 1. Ampliﬁcation was
performed by denaturation at 95°C for 5 min, followed by 35 two-step cycles of 95°C for 10 s and 60°C
for 30 s. Melting curve analysis was carried out at 95°C for 1 min, 55°C for 1 min, and 55 to 95°C for 10 s.
Each reaction was performed in triplicate, and the results for the target gene mRNA were normalized to
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) using the 2ΔΔCT method. Three independent
experiments were performed, and the results are presented as means and 1 standard deviation (SD). Data
were statistically evaluated using the Student t test. A P value of 0.05 was considered statistically
signiﬁcant.
Western blotting. At the indicated times, cells were washed in phosphate-buffered saline (PBS),
detached with Accutase, collected, counted, and centrifuged. Cell pellets were snap-frozen in liquid
nitrogen and stored at 80°C until completion of the time course. Then, the cell pellets were lysed in
radioimmunoprecipitation assay (RIPA) buffer. Equal amounts of cell lysates were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a polyvinylidene
diﬂuoride (PVDF) membrane (Millipore). After incubation with the indicated primary and corresponding
secondary antibodies, signals were detected using a chemiluminescence instrument and analyzed by
densitometry (ImageJ; National Institutes of Health). At least three sets of independent experiments were
performed, and representative results are shown. HCMV proteins were detected using mouse monoclo-
nal antibodies to IE1 (clone p63-27; IgG2a), IE1/IE2 (CH16), UL44 (IgG1; Virusys), gB (clone 27-156; IgG2b),
or pp65 (IgG1; Virusys). Cellular proteins were detected using a goat polyclonal antibody to SOX2 (clone
L1D6A2; IgG1), a mouse monoclonal antibody to STAT3 (clone 124H6; IgG2a; Cell Signaling Technology),
a rabbit polyclonal antibody to pSTAT3 (Y705) (IgG; Cell Signaling Technology), a mouse monoclonal
antibody to -actin (IgG; Santa Cruz Biotechnology), a rabbit polyclonal antibody to GAPDH (IgG;
Proteintech), or a rabbit polyclonal antibody to lamin B1 (IgG; Proteintech). Secondary antibodies used
were horseradish peroxidase-conjugated sheep anti-mouse IgG (Amersham Bioscience), donkey anti-
rabbit IgG (Amersham Bioscience), and donkey anti-goat IgG (Proteintech).
Immunoﬂuorescence assay. Viral and cellular proteins in cells grown on coverslips were detected
by indirect immunoﬂuorescence analysis as described previously (64). Brieﬂy, NPCs were seeded on
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poly-D-lysine-coated coverslips in uncoated dishes and mock or HCMV infected (MOI  3). Coverslips
were collected at the indicated times postinfection. UL44, SOX2, and STAT3 were stained with the
respective primary antibodies: mouse monoclonal anti-UL44 (IgG1; Virusys), goat polyclonal anti-SOX2
(Santa Cruz Biotechnology), or mouse monoclonal anti-STAT3 (clone 124H6; IgG2a; Cell Signaling
Technology). The secondary antibodies included ﬂuorescein-isothiocyanate (FITC)-conjugated donkey
anti-goat IgG (Jackson ImmunoResearch), Alexa Fluor 488-conjugated goat anti-mouse IgG1 (Molecular
Probes), and Alexa Fluor 488-conjugated goat anti-mouse IgG2a (Molecular Probes). Nuclei were coun-
terstained with Hoechst 33342 dye, and coverslips were mounted with antifade mounting solution
containing paraphenylenediamine (65). Images were obtained using a Nikon Eclipse 80i or Nikon Eclipse
Ti-S epiﬂuorescence microscope equipped with a Nikon DS-Ri1 camera and processed using NIS
Elements F3.0 software.
Cellular fractionation. Nucleofected or infected NPCs were washed in precooled PBS and collected
by scraping. Cytosolic and nuclear fractions were prepared using a nuclear-cytosol extraction kit
(Applygen Technologies) following the manufacturer’s instructions. Brieﬂy, cell pellets were lysed in
precooled cytosol extraction buffer A (CEB-A), vortexed, reacted with cytosol extraction buffer B (CEB-B),
vortexed, and centrifuged. The resulting supernatant contained the cytosolic fraction. The precipitate
was washed with CEB-A, lysed in nuclear extraction buffer (NEB), vortexed, and centrifuged. The resulting
supernatant contained the nuclear fraction.
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